ANN MARIE RUSTIA: Open Payments
NPI 1992039622 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,100 in 56 payments from 19 companies in 2025. Trend: 2023 $1,376 · 2024 $823 · 2025 $1,100
Food & beverage: $1,100
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 9 | $150 |
| Amgen Inc. | 5 | $91 |
| Novo Nordisk Inc | 5 | $90 |
| ABBVIE INC. | 4 | $89 |
| AstraZeneca Pharmaceuticals LP | 4 | $87 |
| Lilly USA, LLC | 5 | $87 |
| GlaxoSmithKline, LLC. | 4 | $76 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $68 |
| Inspire Medical Systems, Inc. | 1 | $61 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $50 |
Products named: Veozah, TRELEGY ELLIPTA, Kerendia, JARDIANCE, AIRSUPRA, INSPIRE, OTEZLA, Ozempic.
Industry payments across MD — which companies pay providers there.
